M&G Investment Management LTD Editas Medicine, Inc. Transaction History

M&G Investment Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$26.55 - $40.57 $218,294 - $333,566	-8,222 Closed	0 $0
Q3 2021 Nov 09, 2021	SELL	$39.27 - $72.94 $224,467 - $416,925	-5,716 Reduced 41.01%	8,222 $337,000
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $436,120 - $789,448	13,938 New	13,938 $794,000

240

56.5M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of M&G Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on M&G Investment Management LTD with notifications on news.